sickle cell disease
All Coverage
Global Blood’s sickle cell disease drug heads to the FDA, but questions about patient benefit still linger
Novel gene therapy ‘switch’ for sickle cell disease shows encouraging results in pilot trial
Global Blood’s FDA filing plan for a sickle cell drug is riskier than you think
Global Blood’s sickle cell drug works, but can FDA be persuaded to review it faster?
A CRISPR-based fix for human sickle cells shows promise in mice
Gene therapy for sickle cell moves closer as scientists clear unexpected obstacle
